Actavis PLC (NYSE:ACT)

295.70
Delayed Data
As of Mar 05
 -0.44 / -0.15%
Today’s Change
184.71
Today|||52-Week Range
298.23
+14.88%
Year-to-Date

Today’s Trading

Previous close296.14
Today’s open297.10
Day’s range293.72 - 298.23
Volume2,199,051
Average volume (3 months)2,829,162
Market cap$82.8B
Dividend yield--
Data as of 4:00pm ET, 03/05/2015

Growth & Valuation

Earnings growth (last year)-40.80%
Earnings growth (this year)+22.60%
Earnings growth (next 5 years)+17.50%
Revenue growth (last year)+50.53%
P/E ratioNM
Price/Sales4.33
Price/Book--

Competitors

 Today’s
change
Today’s
% change
AZNAstraZeneca+0.39+0.58%
LLYEli Lilly and Co-0.06-0.08%
ABTAbbott Laboratories+0.43+0.91%
AGNAllergan-0.27-0.11%
Data as of 4:06pm ET, 03/05/2015

Financials

Next reporting dateApril 29, 2015
EPS forecast (this quarter)$4.08
Annual revenue (last year)$13.1B
Annual profit (last year)-$1.6B
Net profit margin-12.48%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
President, Chief Executive Officer &
Director
Brenton L. Saunders
Chief Operating Officer
Robert A. Stewart
Corporate headquarters
Dublin, Dublin

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account